Skip to main content
Clinical Trials/ITMCTR2000003668
ITMCTR2000003668
Not Yet Recruiting
Phase 1

Clinical study on optimal strategy for treatment of Non-active Graves ophthalmopathy

onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Graves ophthalmopathy
Sponsor
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Typical ocular symptoms;
  • 2\. Protrusion degree \& GT;18mm(including unilateral protruding eye);
  • 3\. Inactive protrusion is defined as the clinical scoring standard recommended by the 2008 Chinese Guidelines for the Diagnosis and treatment of thyroid diseases;
  • 4\. Refuse operation patients;
  • 5\. Patients with Graves' disease and normal serum thyroid hormone levels (FT3 and FT4\) for at least two months;
  • 6\. Informed consent, willing to receive treatment and with good predictive compliance, age 18\-70 years old;
  • 7\. TCM syndrome differentiation indicates deficiency of Yang qi and blockage of phlegm and blood stasis.

Exclusion Criteria

  • 1\. Shortness of eyes caused by other causes: case of shortness of eyes, orbital inflammatory pseudotumor, carotid cavernous fistula or dural cavernous sinus short circuit, extraocular muscle lymphoid tumor, primary orbital tumor, eye metastasis tumor, intracranial tumor and other diseases.
  • 2\. Clinical score of protruding eye activity \>\= 3\.
  • 3\. Psychopaths.
  • 4\. Patients with severe primary and secondary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, and with a tendency of hyperthyroidism crisis.
  • 5\. Women who are pregnant or breastfeeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials